
CRISPR Therapeutics AG
NASDAQ:CRSP

Shareholder Yield
Current shareholder yield for CRSP is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CRSP Price
CRISPR Therapeutics AG
Average Annual Return | 58.9% |
Standard Deviation of Annual Returns | 151.63% |
Max Drawdown | -84% |
Market Capitalization | 2.9B USD |
Shares Outstanding | 85 770 000 |
Percentage of Shares Shorted | 26.82% |
Stock Splits
CRSP's latest stock split occurred on Jul 19, 2016
The company executed a 333333-for-100000 stock split, meaning that for every 100000 shares held, investors received 333333 new shares.
The adjusted shares began trading on Jul 19, 2016. This was the only stock split in CRSP's history.